While the human fetal immune system defaults to a program of tolerance, there is a concurrent need for protective immunity to meet the antigenic challenges encountered after birth. Activation of T cells in utero is associated with the fetal inflammatory response, with broad implications for the health of the fetus and of the pregnancy. However, the characteristics of the fetal effector T cells that contribute to this process are largely unknown.
Introduction
In a healthy human pregnancy, fetal immunity is uniquely adapted both to promote tolerance in utero and to subsequently provide protection after birth. Unlike in mice, which lack peripheral TCR-αβ cells in utero (1) , in humans, these T cells begin to populate peripheral organs by 11 to 14 weeks of gestation (2, 3) . Fetal adaptive tolerance is driven in large part by the predilection of naive CD4 + T cells to differentiate into Tregs (4), yet less is known about the development of protective adaptive immunity. Activation of the human fetal immune system and the ensuing fetal inflammatory response are associated with premature termination of pregnancy and severe neonatal morbidity (5, 6) . Activated T cells and reduced suppressive Treg activity are evident during fetal inflammation (7) (8) (9) (10) , and maternal-reactive fetal Th1 cells are implicated in the pathophysiology of preterm birth (PTB) (11) . Animal models of intrauterine inflammation identify the fetal intestine as a potential site for the initiation of immune activation (12) (13) (14) . The existence of organized intestinal lymphoid structures by the second trimester (15) and the presence of antigens within swallowed amniotic fluid point to an instructive role for the intestinal mucosa in the development of fetal adaptive immunity. However, the identity of the effector T cells that contribute to the initiation of inflammation in the human fetal intestine is not known.
Protective fetal adaptive immunity can develop in response to specific pathogens and vaccines (16, 17) , and memory T cells are present in the fetus and infant (18) (19) (20) (21) (22) , indicating that adaptive BACKGROUND. While the human fetal immune system defaults to a program of tolerance, there is a concurrent need for protective immunity to meet the antigenic challenges encountered after birth. Activation of T cells in utero is associated with the fetal inflammatory response, with broad implications for the health of the fetus and of the pregnancy. However, the characteristics of the fetal effector T cells that contribute to this process are largely unknown.
METHODS.
We analyzed primary human fetal lymphoid and mucosal tissues and performed phenotypic, functional, and transcriptional analysis to identify T cells with proinflammatory potential. The frequency and function of fetal-specific effector T cells was assessed in the cord blood of infants with localized and systemic inflammatory pathologies and compared with that of healthy term controls.
RESULTS. We identified a transcriptionally distinct population of CD4 + T cells characterized by expression of the transcription factor promyelocytic leukemia zinc finger (PLZF). PLZF + CD4
+ T cells were specifically enriched in the fetal intestine, possessed an effector memory phenotype, and rapidly produced proinflammatory cytokines. Engagement of the C-type lectin CD161 on these cells inhibited TCR-dependent production of IFN-γ in a fetal-specific manner. IFN-γ-producing PLZF + CD4
+ T cells were enriched in the cord blood of infants with gastroschisis, a natural model of chronic inflammation originating from the intestine, as well as in preterm birth, suggesting these cells contribute to fetal systemic immune activation.
CONCLUSION.
Our work reveals a fetal-specific program of protective immunity whose dysregulation is associated with fetal and neonatal inflammatory pathologies. CD161 contributes to prenatal immune suppression of IFN-γ-producing PLZF + T cells Joanna Halkias, 1 Elze Rackaityte, 2 Sara L. Hillman, 3 Dvir Aran, 4 Ventura F. Mendoza, 5 Lucy R. Marshall, 6 Tippi C. MacKenzie, 5, 7 and Trevor D. Burt cells in the development of protective immunity and their contribution to perinatal immune dysregulation is not known.
Here, we performed a detailed analysis of human CD4 + T cell phenotype and function in fetal lymphoid and mucosal tissues. We show that Vα7. (23) (24) (25) . Promyelocytic leukemia zinc finger (PLZF), a transcriptional regulator that directs the differentiation of innate-like T cells (26, 27) , is widely expressed in human immune cells and is commonly associated with expression of CD161, a C-type lectin receptor (28) . The human fetal thymus uniquely produces a subset of CD4 + T cells, distinct from NKT cells and MAIT cells, that expresses the transcription factor PLZF (29) . However, the role of fetal PLZF + T cells with enhanced capacity for Th1 cytokine production accumulated in the cord blood of infants with gastroschisis, an abdominal wall defect associated with systemic inflammation originating from intestinal injury (30) , and were also increased in the cord blood of preterm infants. Finally, dexamethasone, routinely prescribed to pregnant women in impending preterm labor, inhibited Th1 cyto- , and a fraction of these (~20%) also expressed CD103, suggestive of a T resident memory (TRM) phenotype (Supplemental Figure 2 , C and D). We examined the draining lymph nodes for endogenous expression of Nur77, induction of which is specific to antigen receptor signaling in human T cells (36) . Ex vivo Nur77 expression was significantly more frequent among PLZF + CD4
+ T cells of the MLN as compared with those of the intestine and was consistently low among PLZF -CD4 + T cells (Figure 2 , F and G, and Supplemental Figure 2E) 
CD161
+ cells (Supplemental Figure 3B ), which exhibit phenotypic and functional characteristics of innate T cells (24) . Of these, only a small fraction (4% ± 2%) were MR1 tetramer-positive MAIT cells (Supplemental Figure 3C) (37) . Differential expression of IL-18R and PD1 allowed for the separation of PLZF + from PLZF -memory CD4 + T cells (Supplemental Figure  3, A + T cells, which preferentially expressed transcripts for TCR-β variable 9 (TRBV9), TRBV7-9, and TRBV6-4, suggestive of an oligoclonal repertoire, PLZF + CD4 + T cells were enriched for multiple TCR-α variable (TRAV) genes and did not display preferential TRBV gene expression ( Figure 3C ). The diversity of the T cell repertoire of PLZF + CD4 + T cells was supported by similar Vβ use among both PLZF + and PLZF -memory CD4 + T cells and was comparable to that reported in fetal blood (38) , with no single chain accounting for more than 10% of TCR-Vβ families ( Figure 3D ).
Consistent with a memory phenotype, similarities between SI PLZF + CD4
+ T cells and conventional PLZF -CD4 + T cells revealed transcriptional overlap in the expression of genes associated with T cell activation and memory (21) (Supplemental Figure 4A) . We identified 499 genes that differentiated these 2 memory populations (>2-fold, FDR < 0.05) ( Figure 3B and Supplemental Table 3 ) and utilized the Human Primary Cell Atlas to identify genes that cluster together by cell type using correlation analysis (39) . This approach identified 6 gene clusters, of which clusters 1, 2, and 4 
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-CCR7 -) (TEM); the majority of these expressed PLZF ( Figure 1, A and B) . Immunofluorescent microscopy confirmed abundant PLZF expression among lamina propria (LP) CD4 + T cells ( Figure 1C + T cells increased with advancing gestation, while the ability to produce TNF-α was not significantly associated with gestational age (GA) (Figure 4 , D and E). Among PLZF -CD4 + T cells, neither the ability to produce IFN-γ nor TNF-α correlated with advancing gestation (Supplemental Figure 5 , C and D). PLZF has been associated with production of Th2-type cytokines (26, 27 ), yet production of IL-4 did not differ significantly between PLZF + and PLZF -CD4 + T cells (Figure 4 , F and G) and fetal IL-10-producing CD4 + T cells were nearly undetectable (Supplemental Figure 5E ). PLZF is required for the differentiation of human Th17 cells (43) , and although low in frequency, IL-17-producing cells were significantly more abundant among PLZF Figure 6D ). Unlike classical innatelike T cells, which acquire effector function during thymic development (44), thymic PLZF + CD4 + T cells did not produce detectable IFN-γ in response to these cytokines ( Figure 5K ). The ability to respond to cytokines alone was significantly greater among PLZF + CD4 + TEM cells than PLZF -CD4 + TEM cells (Supplemental Figure 6E ). Our data reveal that SI PLZF + TEM cells are poised to 
Discussion
Perinatal inflammatory pathologies are a primary cause of morbidity and mortality in the fetus and newborn and may affect the developing brain (neurocognitive disorders, cerebral palsy), lung (bronchopulmonary dysplasia), and intestine (necrotizing enterocolitis) (56) . Given the contribution of T cells to the fetal inflammatory response, an understanding of fetal effector T cell identity, function, and regulation is essential for the design of effective strategies to treat or prevent these illnesses. Mouse models have provided critical mechanistic insight of neonatal T cell responses in vivo (57) , yet extrapolating findings between species is hampered by substantial differences in the timing of immune development (1). This study examines the characteristics of human fetal CD4 + T cells supports the hypothesis that antigen recognition may also inform the development of these cells. Reports of microbial prescell IFN-γ production in response to cytokine stimulation alone ( Figure 6E and Supplemental Figure 7D ), which prompted us to examine the effect of CD161 engagement on TCR signaling. However, ligation of CD161 did not appreciably dampen induction of Nur77 in response to TCR activation (Supplemental Figure 7E) . Consistent with previous reports (52) , engagement of CD161 on adult CD4 + T cells did not significantly affect cytokine production ( Figure 6F and Supplemental Figure 7F ). Collectively, our results indicate that ligation of CD161 results in fetal-specific inhibition of cytokine production in response to TCR activation.
IFN-γ-producing fetal PLZF + CD4 + T cells are enriched in the umbilical cord blood of infants with systemic inflammation. We next asked whether we could detect effector PLZF + CD4 + T cells in the circulation of infants with gastroschisis, a congenital abdominal wall defect associated with systemic fetal inflammation thought to originate from the intestine (30) (Supplemental Table 5 ). While present in low numbers in healthy term infants, PLZF + CD4 + T cells were enriched in the cord blood of infants with gastroschisis ( Figure 7, A and B) . The composition of circulating PLZF + CD4 + T cells reflected that of the fetal intestine, with significantly more effector and memory cells in contrast to the primarily naive phenotype of PLZF -CD4 + T cells (Supplemental Figure 8 , A-C). Consistent with an increase in the relative frequency of terminally differentiated effector memory (TEMRA) cells ( Figure 7C ), a subset of TEM cells that reexpress CD45RA after antigenic stimulation, PLZF + CD4 + T cells from gastroschisis samples exhibited higher proportions of IFN-γ-producing cells compared with healthy controls ( Figure 7D and Supplemental Figure 8D ). An increase in the proportion of TNF-α-producing cells among both PLZF + and PLZF -CD4 + T cells was also observed ( Figure 7E and Supplemental Figure 8D ). The Th1 effector potential of cord blood PLZF + T cells was consistently greater than that of their PLZF -counterparts in both healthy controls and infants with gastroschisis (Supplemental Figure 8, E and F) .
The accumulation of circulating effector PLZF + CD4 + T cells during a systemic inflammatory response originating from the intestine led us to examine their involvement in the Th1-mediated immune activation associated with PTB (11) . Analysis of published gene expression data sets (53, 54) revealed that expression of ZBTB16, the gene encoding PLZF, was significantly increased in the cord blood of PTB samples compared with term controls in 2 independent cohorts (Supplemental Figure 9A) . We examined cord blood samples from PTB (<37 weeks) infants (Supplemental Table 6 ), which reaffirmed the previously reported increase in TCM cells and the concomitant decrease in naive cells among CD4 + T cells in PTB as compared with term (>37 weeks) controls (Supplemental Figure 9 , B and C, and refs. 8, 11) . In agreement with the gene expression analysis, the frequency of circulating PLZF + CD4 + T cells was significantly higher in PTB compared with term infants (Figure 7, F tive immunity. Expression of PLZF is required for thymic differentiation of NKT cells and is sufficient to confer a memory phenotype and effector function (26, 27 (29) . Determining whether antigen recognition by fetal PLZF + CD4 + T cells in the periphery is restricted to MHC class II and understanding the specific nature of these antigens will help clarify the development of these cells in future studies. + T cells are ideally situated to encounter antigen or inflammatory modulators in swallowed amniotic fluid. Yet whether immune activation in the intestine contributes to the effector T cell pool in the circulation is unclear. In mice, the vast majorience in human meconium and amniotic fluid (61) (62) (63) point to the growing importance of understanding the development of protective fetal immunity and the effects of bacterial priming that may occur in utero. Intestinal luminal antigens may also direct surface acquisition of LLT1 on fetal macrophages, as LLT1 expression is robustly elicited in human APCs in response to TLR and B cell receptor activation (49, 52, 64) . Loss of placental hormones and the sudden increase in oxygen availability at birth, the introduction of an oral diet, and other environmental exposures likely exert different pressures on mucosal immune composition and may explain the absence of PLZF + T cells and the inhibitory effect of CD161 engagement. CD161 ligation inhibits human NK cells (45, 64, 67) , but exerts costimulatory effects on NKT cells (46) and MAIT cells (47) . Perhaps due to conditions unique to the in utero environment, our results demonstrate a fetal-specific inhibitory effect that is the opposite of the primarily costimulatory role for CD161 on adult human innate T cells. CD161 signaling may influence activation downstream of TCR signaling, yet we did not observe an effect on expression of Nur77. Induction of Nur77 in human CD4 + T cells is dependent on PI3K and MEK, as well as Akt and mTOR complex 1 (mTORC1) and mTORC2, and less sensitive to mTORC1 alone and JAK/Stat signaling (36) . CD161 engagement results in increased production of ceramide through induction of acid sphingomyelinase (ASM) activity and mediates downstream signaling cascades, including STAT3 and mTOR (68, 69) . Thus, the mechanism of CD161 inhibition may involve JAK/Stat and mTORC1 signaling pathways independent of Nur77 induction and will be explored in future studies. The differential enrichment of numerous negative T cell regulators in the gene signature of SI PLZF + CD4 + T cells suggests the existence of additional cell-intrinsic mechanisms of regulation to promote immune homeostasis in utero.
Fetal SI PLZF + CD4 + T cells share functional and transcriptional attributes with both conventional and innate-like T cells. The development of TRM cells is closely coupled to anatomic location (41, 70) , suggesting that the intestinal microenvironment may be responsible for the enhanced cytokine production of SI PLZF + CD4 + T cells as well as the preferential accumulation of CD161 + cells. The appearance of Th1 effector cells in the SI precedes that in the LI and supports the regional compartmentalization of the effector response. However, to what extent SI PLZF + CD4 + T cells recirculate to other organs and whether they represent a different population than those in lymphoid tissues is not known. A Th1 effector phenotype is also evident in human fetal γδ T cells, Vα7. Immunohistochemistry. Intestinal segments were fixed in 4% paraformaldehyde for 10 minutes and dehydrated in a sucrose gradient prior to embedding in OCT. Embedded tissues were frozen on dry ice and stored at -80°C, and 10 μm thin cryosections were mounted on frosted charged slides. Histological work, imaging, and image processing were performed by the Gladstone Institutes' Histology and Light Microscopy Core. Slides were fixed in acetone for 5 minutes at -20°C, rehydrated in PBS for 10 minutes, rinsed in 0.05% PBS-Tween, and permeabilized in 0.1% PBS-Triton X-100 for 15 minutes at room temperature (RT). Slides were blocked using 1% BSA, 0.1% fish skin gelatin, 0.5% Triton X-100,and 0.05% Na-Azide in PBS for 2 hours ty of memory CD8 + T cells within nonlymphoid tissue are TRM, whereas secondary lymphoid organs contain mostly recirculating (TEM and TCM) subsets (75 + T cells gradually disappear in healthy infants and whether early gut dysbiosis results in the persistence of these T cells will be explored in futures studies.
These data add to our knowledge of the composition and function of the protective arm of the fetal adaptive immune system, in particular to the establishment of tissue-localized responses. The presence of a sizeable fraction of PLZF + CD4
+ T cells with Th1 effector potential offers a more nuanced appreciation of human fetal immune development and highlights the unique challenges faced by the developing immune system as it transitions from a program of tolerance to one of protective immunity during the last trimester of pregnancy. We have identified a mechanism of fetal-specific immune suppression through CD161 blockade, which likely works in concert with multiple other regulatory mechanisms to actively promote immune suppression in utero (4, 77, 78) and could be harnessed therapeutically for the prevention or treatment of fetal and neonatal inflammatory pathologies. Beyond the perinatal period, expanding our knowledge of human fetal immune development and function is of utmost importance to our understanding of the early origins of predisposition to adult inflammatory diseases.
Methods
Cell isolation. PBMCs from adult and cord blood were isolated by Ficoll-Histopaque (Sigma-Aldrich) gradient centrifugation and cryopreserved in freezing medium (90% FBS + 10% DMSO; ATCC) and analyzed in batches. Fetal and adult organs were collected into cold RPMI with 10% FCS, 10 mM HEPES, penicillin, streptomycin, 0.1 mM 2-β-mercaptoethanol, 2 mM l-glutamine, and nonessential amino acids (cgRPMI medium), transported on ice, and processed within 2 hours of collection. The SI and colon were dissected from the mesentery, opened longitudinally, and cut into 1 cm sections. Mucus was removed with 3 washes in 1 mM DTT in PBS for 10 minutes. The epithelial layer was removed with 3 washes in 1 mM EDTA in PBS for 20 minutes. The intestine, MLN, liver, lung, and spleen were minced into smaller pieces and digested with freshly prepared 3 mg/mL collagenase IV (Life Technologies) and 10 mg/mL DNAse (Roche) in cgRPMI for 30 minutes, and dissociated cells were filtered through a 70 μm strainer. Cells were separated in a 20%/40%/80% Percoll density gradient at 400 g for 40 minutes. T cells were recovered at the 40%-80% interface, APCs were recovered at the 20%-40% interface, and all cells were washed twice in cgRPMI. All washes and incubations were performed in a shaking (200 rpm) water bath at 37°C. Thymocytes were isolated by gently pressing small pieces of thymus though a 70 μm strainer. Viability was measured with Trypan Blue (Sigma Aldrich).
Antibodies and flow cytometry. Intestinal LP T cells were isolated by negative selection using the EasySep Human T Cell Isolation jci.org Volume 129 Number 9 September 2019
the Nugen/Nextera XT Library Prep Kit (Illumina), and 15 samples (5 donors, 3 T cell subsets) were sequenced on an Illumina HiSeq 4000 by the Functional Genomics Core Facility at UCSF. The reads from the Illumina HiSeq sequencer in fastq format were verified for quality control using the fastqc software package. Reads were aligned to the human genome (hg38) and read counts aggregated by gene using the Ensembl GRCh38.78 annotation using STAR (79) . Differential gene expression analysis was performed with the DESeq2, version 1.16.1, package (80) . Statistics. Groups were compared with Prism, version 6, software (GraphPad). Data were analyzed using Wilcoxon's test for paired nonparametric data, Mann-Whitney U test for unpaired nonparametric data, and the Kruskal-Wallis with Dunn's multiple comparison test for comparison of 3 or more groups. Box plot rectangles show first to third quartile, the line shows the median, and the whiskers represent minimum and maximum values, unless otherwise stated. Correlation analysis was measured by Spearman's correlation coefficient. Bar plots represent the mean and the SEM. P < 0.05 was considered significant. Linear mixed effects (LME) modeling was used to evaluate significance in dose-response inhibition to CD161 antibody crosslinking. Principle component analysis and accompanying confidence intervals were performed using combined functions in the R packages stats, vegan, and ggplot2, and PERMANOVA analysis was used to assess the significance of the Euclidean distances between the groups. Heatmaps were generated using the R packages heatmap and circlize. A coexpression analysis was performed for the differentially expressed (DE) genes using the Human Primary Cell Atlas (39) . This atlas contains 713 microarray samples of a wide range of pure cell types and states. The complexity of the data set was reduced to the median gene expression per cell state (n = 157), and Spearman's correlation coefficients were calculated for each pair of DE genes, revealing clusters of genes that are coexpressed in the same set of cell types. Gene clusters were analyzed for overlap with KEGG and GO biological processes gene sets using the Molecular Signatures Database (MSigDB) (81, 82) . No statistical methods were used to predetermine sample size. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment.
Study approval. Human fetal tissues (15 to 23 weeks GA) were obtained from San Francisco General Hospital (San Francisco, California, USA) from terminations of pregnancy after maternal written informed consent with approval from and under the guidelines of the UCSF Research Protection program. Samples were excluded in the cases of (a) known maternal infection, (b) intrauterine fetal demise, and/or (c) known or suspected chromosomal abnormality. Adult intestinal tissues were obtained after written informed consent from the UCSF Biospecimen Resources Program. Adult SI was obtained from routine resections during Whipple procedures, and adult colon was obtained during hemicolectomies and surgical resections. PBMCs derived from Trima residues from Trima Apheresis collection kits were obtained from healthy donors after written informed consent at the Blood Centers of the Pacific. Approval for healthy, term umbilical cord blood collection was obtained from the University of Texas MD Anderson Cancer Center (Houston, Texas, USA) with written informed consent between January 2017 and June 2018. Eligibility criteria for term infant control samples included healthy infants delivered at more than 37 weeks GA; samand stained with purified anti-CD3 (clone Hit3a; BD BiosciencesPharmingen, catalog 555336) and anti-PLZF (clone NBPI-80894, Novus Biologicals, catalog NBPI-80894) overnight at 4°C, followed by anti-CD4-eFluor 570 (N1UG0, Thermo Fisher, catalog 41-2444-82) at RT for 3 hours. Slides were incubated with secondary antibody goat anti-mouse-DyLight 488 (Thermo Fisher, catalog 35502) and goat anti-rabbit 633 (Thermo Fisher, catalog A-21070) for 1 hour at RT, stained with DAPI (Invitrogen) for 10 minutes at RT, and mounted with Fluormount-G (EMS). Images were captured with a Zeiss Cell Observer Spinning Disk microscope (Carl Zeiss Microscopy) equipped with 405 nm, 488 nm, 561 nm, 633 nm lasers, a prime 95b sCMOS camera (Photometrics), and Zeiss Zen imaging software.
T cell stimulation and CD161 inhibition. For detection of basal cytokine potential, single cell suspensions from various tissues were cultured directly ex vivo in a 96-well U-bottom plate in cgRPMI and stimulated with 50 ng/ml PMA (Santa Cruz Biotechnology Inc., catalog SC-3576) and 5 μg/ml ionomycin (Sigma-Aldrich) in the presence of Brefeldin A (Sigma-Aldrich, catalog B7651-5MG) for 3 hours at 37°C in 4% O 2 to mimic intrauterine hypoxia. For Nur77 induction, T cells were cultured at 500 K/well in 96-well plates and stimulated with plate-bound anti-CD3 (clone HIT3a, BioLegend, catalog 300313) at 1 μg/ml and soluble anti-CD28 (CD28.2) at 2 μg/ml for 4 hours at 37°C in 4% O 2 . For cytokine production, T cells were cultured at 250 K/well in 96-well plates and stimulated with plate-bound anti-CD3 at 1 μg/ml and soluble anti-CD28 (CD28.2, Invitrogen, catalog MA1-20792) at 2 μg/ml, or cells were activated with 50 μg IL-12 (PeproTech, catalog 200-12) and IL-18 (R&D Systems, catalog 9124-IL-050) at 50 ng/mL for 16-20 hours at 37°C in 4% O 2 , and Brefeldin A was added for the last 4 hours. After stimulation, cells were stained for intracellular cytokine production as described above. For the inhibition assays, T cells were first incubated with anti-CD161 biotin mAbs (clone HP3G10, BioLegend, catalog 339932, or clone 191B8, Miltenyi Biotec, catalog 130-092-906) or isotype-biotin controls IgG1 (MOPC-21, BioLegend, catalog 400104) and IgG2a (MOPC-173, BioLegend, catalog 400204) for 15 minutes, washed, and crosslinked with Anti-Biotin Cocktail (STEMCELL Technologies) at 1:50 dilution during stimulation with anti-CD3/anti-CD28 or cytokines as described above. For glucocorticoid-induced apoptosis assays, T cells were incubated in the presence of dexamethasone (SigmaAldrich) (10 -6 -10 -9 M) or ethanol vehicle control alone or stimulated with Immunocult Human CD3/CD28/CD2 T cell activator beads (STEMCELL Technologies, catalog 10990) for 36 hours. T cells were then stained for annexin V using the Annexin V Apoptosis Detection Kit FITC (eBioscience, catalog 88-8005-74) according to the manufacturer's instructions, followed by intracellular staining for PLZF and/or intracellular cytokine production as above.
T cell isolation and RNA extraction for RNA-Seq. PLZF + and PLZF -CD4 + TCR-β + T cells were sorted using FACSAria2 SORP (BD Biosciences). T cells were isolated as described above from the intestine of 5 individual samples. MAIT cells were pooled from the intestine and MLN for RNA-Seq as outlined in Supplemental Figure 3A , and 10 4 cells were collected per subset for each sample. Postsort purity was determined by flow cytometry following intracellular staining for PLZF as above and was more than 92% for PLZF -T cells and 
